Sartorius Stedim Biotech S.A.
FR ˙ ENXTPA ˙ FR0013154002
178,90 € ↓ -4,80 (-2,61%)
2026-06-05
DEL PRIS
SecurityFR:DIM / Sartorius Stedim Biotech S.A.
InstitutionBrighthouse Funds Trust II - Baillie Gifford International Stock Portfolio Class A
Latest Disclosed Ownership34,480 shares
Latest Disclosed Value $ 8,251,895
Brighthouse Funds Trust II - Baillie Gifford International Stock Portfolio Class A reports 5.07% decrease in ownership of DIM / Sartorius Stedim Biotech S.A.

On August 27, 2025 - Brighthouse Funds Trust II - Baillie Gifford International Stock Portfolio Class A filed a NPORT-P form disclosing ownership of 34,480 shares of Sartorius Stedim Biotech S.A. (FR:DIM) valued at $6,992,544 USD as of June 30, 2025. The entity filed a previous NPORT-P on May 27, 2025 disclosing 36,320 shares of Sartorius Stedim Biotech S.A.. This represents a change in shares of -5.07% during the quarter. The current value of the position is $6,168,472 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2025-08-27 2025-06-30 NP Sartorius Stedim Biotech EC FR0013154002 34,480 -1,840 -5.07 8,252 14.23 0.5944
2025-05-27 2025-03-31 NP Sartorius Stedim Biotech EC FR0013154002 36,320 -1,787 -4.69 7,223 -2.80 0.5490
2025-02-28 2024-12-31 NP Sartorius Stedim Biotech EC FR0013154002 38,107 -2,857 -6.97 7,431 -13.32 0.5590
2024-11-26 2024-09-30 NP Sartorius Stedim Biotech EC FR0013154002 40,964 -2,236 -5.18 8,574 21.47 0.5631
2024-08-29 2024-06-30 NP Sartorius Stedim Biotech EC FR0013154002 43,200 0 0.00 7,059 -42.66 0.4821
2024-05-28 2024-03-31 NP Sartorius Stedim Biotech EC FR0013154002 43,200 1,245 2.97 12,311 10.47 0.8129
2024-02-29 2023-12-31 NP Sartorius Stedim Biotech EC FR0013154002 41,955 -2,153 -4.88 11,143 6.16 0.7327
2023-11-29 2023-09-30 NP Sartorius Stedim Biotech EC FR0013154002 44,108 0 0.00 10,497 -4.77 0.7792
2023-08-28 2023-06-30 NP Sartorius Stedim Biotech EC FR0013154002 44,108 -1,524 -3.34 11,022 -21.39 0.7278
2023-05-26 2023-03-31 NP Sartorius Stedim Biotech EC FR0013154002 45,632 -2,878 -5.93 14,022 -11.28 0.8840
2023-02-28 2022-12-31 NP Sartorius Stedim Biotech EC FR0013154002 48,510 17,408 55.97 15,804 66.24 1.0432
2022-11-28 2022-09-30 NP Sartorius Stedim Biotech EC FR0013154002 31,102 31,102 9,508 0.7256
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.